Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
Article in Rheumatology and Therapy (February 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
Article in Modern Rheumatology (July 2022)
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry.
Article in The Journal of Rheumatology (February 2022)